Color adaptive therapeutic light control system
US-9205277-B2 · Dec 8, 2015 · US
US9403030B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9403030-B2 |
| Application number | US-201214005561-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 25, 2012 |
| Priority date | Mar 27, 2011 |
| Publication date | Aug 2, 2016 |
| Grant date | Aug 2, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade β-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe.
Opening claim text (preview).
The invention claimed is: 1. An apparatus for administration of biostimulatory phototherapy radiation to a bone of a subject, the apparatus comprising: a transparent output interface, an appliance adapted to hold the output interface into contact with a skin surface overlying the bone or into contact with the bone; and a source of coherent light, which is configured to emit the radiation through the output interface so as to irradiate marrow of the bone at a sufficient intensity to improve brain function when the source of coherent light avoids irradiating a brain of the subject. 2. The apparatus according to claim 1 , wherein the coherent light has a wavelength between 630-910 nm. 3. The apparatus according to claim 1 , wherein the source of coherent light is configured to emit the radiation at an intensity sufficient to engender removal of β-amyloid from the brain of the subject. 4. The apparatus according to claim 1 , wherein the source of coherent light is a laser. 5. The apparatus according to claim 1 , wherein the output interface has multiple openings comprising circumferentially oriented or longitudinally oriented slots. 6. The apparatus according to claim 1 , wherein the source of coherent light comprises multiple laser probes that emit the radiation to the marrow simultaneously. 7. The apparatus according to claim 1 , wherein the output interface has an axis and a circumference about the axis, the output interface comprising fiberoptic elements produce a light radiation directed radially to the axis, the radiation being distributed about the entire circumference. 8. A method of phototherapy, comprising the step of: responsively to a determination that Alzheimer's disease exists or is developing in a brain of a living subject irradiating marrow within a bone of the subject that is remote from the brain with biostimulatory radiation of sufficient intensity to improve brain function while avoiding irradiating the brain of the subject. 9. The method according to claim 8 , wherein irradiating comprises emitting the radiation at an intensity sufficient to engender removal of β-amyloid from the brain of the subject. 10. The method according claim 8 , wherein removal of β-amyloid is mediated by mesenchymal stem cells that are stimulated by the radiation. 11. The method according to claim 8 , wherein irradiating is performed by delivering visible or infrared light energy to the marrow by: positioning a probe comprising a source of coherent light on a body surface of the subject or directly on the bone; and directing the energy from the probe toward the marrow. 12. The method according to claim 11 , wherein the source of coherent light is a laser. 13. The method according to claim 11 , wherein the source of coherent light is a light-emitting diode. 14. The method according to claim 11 , wherein directing the energy from the probe is performed in a continuous wave mode of operation. 15. The method according to claim 11 , wherein directing the energy from the probe is performed in a pulsed mode of operation. 16. The method according to claim 8 , wherein irradiating is performed by delivering visible or infrared light energy to the marrow by: positioning a laser probe beneath a body surface of the subject; and directing the energy from the laser probe toward the marrow. 17. The method according to claim 16 , wherein positioning the laser probe comprises inserting a distal portion of the laser probe into a medullary cavity of the bone and irradiating is performed via directing light through multiple openings in the distal portion of the laser probe. 18. The method according to claim 17 , wherein the multiple openings are circumferentially oriented slots on a fiberoptic element, the slots distributed so as to emit light via the fiberoptic element radially over 360 degrees about a longitudinal axis of the laser probe. 19. The method according to claim 17 , wherein the multiple openings are longitudinally oriented slots. 20. The method according to claim 8 , wherein irradiating comprises positioning multiple laser probes on the subject and directing the radiation from the multiple laser probes to the marrow simultaneously. 21. The method according to claim 8 , wherein the bone comprises a plurality of bones, including at least a first bone and a second bone, wherein irradiating comprises directing first and second ones of the multiple laser probes to the first bone and the second bone, respectively. 22. The method according to claim 8 , wherein the radiation has a wavelength of 804 nm at a power of 10-14 mW/cm 2 and an exposure duration of 100-120 seconds. 23. The method according to claim 8 , wherein a beam diameter of the radiation within the marrow is from 3-8 cm. 24. The method according to claim 8 , wherein irradiating is performed multiple times according to a cyclic dosage schedule. 25. The method according to claim 24 , wherein the cyclic dosage schedule comprises six doses administered twice a week. 26. The method according to claim 8 , wherein the bone is a tibia. 27. The method according to claim 8 , wherein the bone comprises one or more bones of a pelvic girdle. 28. The method according to claim 8 , wherein the bone comprises one or more bones of an upper extremity and upper limb girdle. 29. The method according to claim 8 , wherein the bone comprises one or more of a rib, vertebra and sternum.
Diodes · CPC title
infrared · CPC title
using probes penetrating tissue; interstitial probes · CPC title
comprising light transmitting means, e.g. optical fibres · CPC title
Human Necessities · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.